Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
ICICI Pru Nifty Pharma Index Fund Reg IDCW |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.56 |
Equity |
99.85 |
Trep |
0.71 |
|
|
Concentration Analysis |
Top 5 Holdings |
62.08% |
Top 10 Holdings |
80.37% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.85 |
Cash |
0.15 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.93 |
PE Ratio |
31.65 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
24.66 |
Cipla Limited |
11.09 |
DIVI LABORATORIES LTD |
9.98 |
Dr Reddys Laboratories Limited |
9.76 |
Lupin Limited |
6.59 |
Aurobindo Pharma Limited |
4.24 |
Torrent Pharmaceuticals Limited |
3.97 |
Alkem Laboratories Limited |
3.53 |
Mankind Pharma Limited |
3.41 |
Zydus Lifesciences Limited |
3.14 |
Laurus Labs Limited |
2.97 |
Glenmark Pharmaceuticals Limited |
2.76 |
IPCA Laboratories Limited |
2.64 |
Abbott India Limited |
2.26 |
Biocon Limited |
1.95 |
Gland Pharma Limited |
1.77 |
J B Chemicals and Pharma Ltd |
1.68 |
Ajanta Pharma Limited |
1.50 |
Natco Pharma Limited |
0.99 |
Granules India Limited |
0.96 |
TREPS |
0.71 |
Net Current Assets |
-0.56 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|